UK markets closed

Northwest Biotherapeutics, Inc. (NBYB.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.4120-0.0180 (-4.19%)
At close: 09:59PM CEST
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
2,126
6,965
15,169
9,983
Total cash
2,126
6,965
15,169
9,983
Other current assets
1,999
2,460
2,121
-
Total current assets
4,125
9,425
17,290
15,511
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
25,317
21,907
21,000
15,359
Accumulated depreciation
-3,856
-2,272
-1,084
-756
Net property, plant and equipment
21,461
19,635
19,916
14,603
Goodwill
626
626
626
626
Intangible assets
1,292
1,292
1,292
1,292
Other long-term assets
361
345
1,036
867
Total non-current assets
23,740
21,898
22,870
17,388
Total assets
27,865
31,323
40,160
32,899
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
20,480
15,538
7,239
6,267
Accounts payable
13,788
17,642
10,947
12,743
Other current liabilities
1,434
83,803
107,034
363,247
Total current liabilities
45,204
126,005
133,769
382,424
Non-current liabilities
Long-term debt
20,312
5,991
25,156
8,507
Other long-term liabilities
4,950
-
-
-
Total non-current liabilities
48,434
33,421
30,382
13,423
Total liabilities
93,638
159,426
164,151
395,847
Stockholders' equity
Common stock
1,175
1,068
948
830
Retained earnings
-1,359,721
-1,297,122
-1,192,090
-1,371,216
Accumulated other comprehensive income
1,536
3,145
357
-1,148
Total stockholders' equity
-65,773
-128,103
-123,991
-362,948
Total liabilities and stockholders' equity
27,865
31,323
40,160
32,899